Novartis Investigative Site

Summary

Novartis Investigative Site is a medical facility located in HALIFAX, Nova Scotia. This center is recognized for care of Multiple Sclerosis, Heart Failure, Psoriasis, Breast Cancer, Cancer and other specialties. Novartis Investigative Site is involved with conducting 42 clinical trials across 66 conditions. There are 0 research doctors associated with this hospital, such as .

Top PIs

Clinical Trials running at Novartis Investigative Site

Prostate Cancer

Breast Cancer

Breast cancer

Relapse

Motor and sensory neuropathy

Multiple Sclerosis

Lutetium (177Lu) Vipivotide Tetraxetan

for Prostate Cancer

The purpose of this study is to evaluate the efficacy and safety of lutetium (177Lu) vipivotide tetraxetan (AAA617) in participants with oligometastatic prostate cancer (OMPC) progressing after definitive therapy to their primary tumor. The data generated from this study will provide evidence for the treatment of AAA617 in early-stage prostate cancer patients to control recurrent tumor from progressing to fatal metastatic disease while preserving quality of life by delaying treatment with androgen deprivation therapy (ADT).

Recruiting

2 awards

Phase 3

6 criteria

AAA617 Alone or Combined With ARPI

for Prostate Cancer

This trial is testing a new radioactive drug called AAA617, alone or with hormone-blocking medication, in men with a specific type of prostate cancer that hasn't spread and doesn't respond to usual treatments. The drug aims to kill cancer cells with radiation while the hormone blocker stops their growth.

Recruiting

1 award

Phase 2

20 criteria